Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study

In 2018, the World Health Organization recommended a 6-month four-drug regimen (rifampicin, ethambutol, pyrazinamide, and levofloxacin) for the treatment of isoniazid-monoresistant tuberculosis. However, the regimen had very low certainty. This cohort study assessed the impact of fluoroquinolone use...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Jinsoo, Kim, Hyung Woo, Kang, Ji Young, Kim, Sung Kyoung, Kim, Jin Woo, Kim, Yong Hyun, Yoon, Hyoung Kyu, Lee, Sang Haak, Kim, Ju Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387806/
https://www.ncbi.nlm.nih.gov/pubmed/35980991
http://dx.doi.org/10.1371/journal.pone.0273263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387806/
https://www.ncbi.nlm.nih.gov/pubmed/35980991
http://dx.doi.org/10.1371/journal.pone.0273263

Ejemplares similares